Last $70.80 USD
Change Today -0.75 / -1.05%
Volume 804.9K
BMRN On Other Exchanges
Symbol
Exchange
Frankfurt
As of 5:20 PM 08/27/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Daniel K. Spiegelman B.A., M.B.A.

Chief Financial Officer and Executive Vice President, BioMarin Pharmaceutical Inc.
AgeTotal Calculated CompensationThis person is connected to 56 board members in 3 different organizations across 10 different industries.

See Board Relationships
55$4,029,289
As of Fiscal Year 2013

Background*

Mr. Daniel K. Spiegelman, also known as Dan, B.A., M.B.A. has been the Chief Financial Officer and Executive Vice President at BioMarin Pharmaceutical Inc. since May 2012. From May 2009 to May 2012, Mr. Spiegelman served as a strategic and financial consultant to a portfolio of public and private life science companies. He served as the Chief Financial Officer of CV Therapeutics Inc., from January 1998 to May 2009 and its Senior Vice President until May 2009. Mr. Spiegelman ...

Read Full Background

Corporate Headquarters*

770 Lindaro Street
San Rafael, California 94901

United States

Phone: 415-506-6700
Fax: 415-382-7889

Board Members Memberships*

Director
2004-2012
Former Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
2004-N/A
Former Independent Director, Chairman of Audit Committee and Member of Dividend Committee
2006-N/A
Former Director
2008-Present
Director, Chairman of Audit Committee and Member of Corporate Governance & Nominating Committee
2009-2012
Former Director and Chairman of Audit Committee
2010-2014
Former Director and Chairman of Audit Committee
2014-Present
Chairman of The Board

Education*

BA
The Leland Stanford Junior University
MBA
Stanford Graduate School of Business

Other Affiliations*

Annual Compensation*

Salary$457,769
Total Annual Compensation$457,769

Stock Options*

Restricted Stock Awards$895,092
All Other Compensation$6,838
Exercised Options46,000
Exercised Options Value$1,259,411
Exercisable Options14,708
Exercisable Options Value$137,380
Unexercisable Options141,292
Unexercisable Options Value$2,530,110
Total Value of Options$3,926,901
Total Number of Options202,000

Total Compensation*

Total Annual Cash Compensation$741,807
Total Short Term Compensation$457,769
Other Long Term Compensation$901,930
Total Calculated Compensation$4,029,289
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BMRN:US $70.80 USD -0.75

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOMARIN PHARMACEUTICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.